AIM: to observe the changes of hepatic fibrosis index, clinical symptom, physical sign and hepatic function after the patients were treated treatment with reduced glutathione hormone.
目的：观察酒精性肝炎患者使用还原型谷胱甘肽治疗后肝纤维化指标的改善情况及临床症状、体征、肝功能的变化。
AIM: to observe the changes of hepatic fibrosis index, clinical symptom, physical sign and hepatic function after the patients were treated treatment with reduced glutathione hormone.
目的：观察酒精性肝炎患者使用还原型谷胱甘肽治疗后肝纤维化指标的改善情况及临床症状、体征、肝功能的变化。
应用推荐